Heart failure and anemia

Basit Öğe Kaydı
dc.contributor.authorKarahan Z.
dc.contributor.authorIltümür K.
dc.contributor.authorToprak N.
dc.date.accessioned2024-04-24T18:43:40Z
dc.date.available2024-04-24T18:43:40Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description.abstractAnemia is commonly observed in patients with heart failure and is associated with aggravating symptoms. The cause of anemia in heart failure is not completely understood, but it is likely to be the result of a combination of factors including hemodilution, inflammatory activation, renal dysfunction, malnutrition due to right-sided heart failure, and drug therapy. Correcting anemia results in beneficial effects on cardiac function and morbidity in patients with heart failure. However, it should be recalled that aggressive treatment of anemia may also lead to adverse effects such as hypertension, thrombosis, and endothelial activation.en_US
dc.identifier.endpage65en_US
dc.identifier.issn1016-5169
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-39749094984en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage59en_US
dc.identifier.urihttps://hdl.handle.net/11468/24278
dc.identifier.volume34en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnemia, İron-Deficiency/Drug Therapyen_US
dc.subjectAnemia/Complications/Therapyen_US
dc.subjectErythropoietin/Therapeutic Useen_US
dc.subjectHeart Failure, Congestiveen_US
dc.subjectHematocriten_US
dc.subjectHemoglobinsen_US
dc.subjectIronen_US
dc.subjectKidney Failure, Chronicen_US
dc.subjectRisk Factorsen_US
dc.titleHeart failure and anemiaen_US
dc.title.alternativeKalp yetersizliği ve anemien_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu